Literature DB >> 17308867

Temporal coincidence between AMAN type of GBS and myasthenia gravis.

Jörg Kraus, Inga Teismann, Christoph Kellinghaus, Thomas Duning, E Bernd Ringelstein, Darius G Nabavi, Wolf-Rüdiger Schäbitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17308867     DOI： 10.1007/s00415-006-0366-x

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  10 in total

1.  Myasthenia gravis and recurrent Guillain-Barré syndrome.

Authors:  B Carlander; J Touchon; M Georgesco; J Cadilhac
Journal:  Neurology       Date:  1991-11       Impact factor: 9.910

Review 2.  Guillain-Barré syndrome.

Authors:  A F Hahn
Journal:  Lancet       Date:  1998-08-22       Impact factor: 79.321

3.  Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.

Authors:  B C Jacobs; P A van Doorn; P I Schmitz; A P Tio-Gillen; P Herbrink; L H Visser; H Hooijkass; F G van der Meché
Journal:  Ann Neurol       Date:  1996-08       Impact factor: 10.422

4.  Acute polyneuropathy combined with myasthenia gravis.

Authors:  I Regev; N Bornstein; R Carasso; Y Vardi
Journal:  Acta Neurol Scand       Date:  1982-06       Impact factor: 3.209

5.  IgG from patients with Guillain-Barré syndrome interact with nicotinic acetylcholine receptor channels.

Authors:  K Krampfl; B Mohammadi; B Buchwald; K Jahn; R Dengler; K V Toyka; J Bufler
Journal:  Muscle Nerve       Date:  2003-04       Impact factor: 3.217

Review 6.  Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes.

Authors:  N Yuki
Journal:  Lancet Infect Dis       Date:  2001-08       Impact factor: 25.071

Review 7.  Myasthenia gravis: clinical, immunological, and therapeutic advances.

Authors:  F Romi; N E Gilhus; J A Aarli
Journal:  Acta Neurol Scand       Date:  2005-02       Impact factor: 3.209

8.  [Anti-GQ1b IgG-negative case of overlapping Fisher's and Gullain-Barré syndromes after Campylobacter jejuni (PEN 19) enteritis].

Authors:  Y Hayashi; M Koga; M Takahashi; A Uchida; N Yuki
Journal:  Rinsho Shinkeigaku       Date:  2001-11

9.  [Polyradiculoneuritis and myasthenia gravis (author's transl)].

Authors:  G Bourouresques; F Delpuech; R Giudicelli; M Poncet; J P Kleisbauer; F Daniel; B Tafani; R Khalil
Journal:  Nouv Presse Med       Date:  1981-01-31

10.  Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients.

Authors:  C W Ang; J D Laman; H J Willison; E R Wagner; H P Endtz; M A De Klerk; A P Tio-Gillen; N Van den Braak; B C Jacobs; P A Van Doorn
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441
  10 in total
  4 in total

1.  Temporal coincidence of myasthenia gravis and Guillain Barré syndrome associated with Hashimoto thyroiditis.

Authors:  Jing Ye Wang; Jie Pan; Ben Yan Luo; Yan Yan Zhang
Journal:  Neurol Sci       Date:  2011-04-14       Impact factor: 3.307

2.  Simultaneous Combined Myositis, Inflammatory Polyneuropathy, and Overlap Myasthenic Syndrome.

Authors:  Stéphane Mathis; Laurent Magy; Philippe Corcia; Karima Ghorab; Laurence Richard; Jonathan Ciron; Mathilde Duchesne; Jean-Michel Vallat
Journal:  Case Rep Neurol Med       Date:  2016-12-01

Review 3.  Guillain-Barré syndrome associated with myasthenia gravis: Three cases report and a literature review.

Authors:  Yayun Cao; Mengcui Gui; Suqiong Ji; Bitao Bu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 4.  The clinical features of patients concurrent with Guillain-Barre syndrome and myasthenia gravis.

Authors:  Junliang Yuan; Juan Zhang; Bingwei Zhang; Wenli Hu
Journal:  Neurosciences (Riyadh)       Date:  2018-01       Impact factor: 0.906
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.